1-METHYL-4-(4-PIPERIDINYLMETHYL)PIPERIDINE, 95%, 250mg

Acide 4-azidobenzoïque, min 97 %, 5 mg, emballage plastique.

4-allyl-5-[(3-methylphenoxy)methyl]-4H-1,2,4-triazole-3-thiol, 95.0%, 1g

2-Bromo-N-(4-(trifluoromethyl)phenyl)acetamide, 95.0%, 25g

Methyl 5-hydroxy-2-nitrobenzoate, 97%, 5g

3-Chloro-4-((6-methylpyridin-3-yl)oxy)aniline, 95%, 100mg

o-Diethylbenzene, 97.0%, 10g

(1-ethylpiperidin-3-yl)methanol, 95.0%, 1g

(2R)-1-[(TERT-BUTOXY)CARBONYL]-2-PROPYLPYRROLIDINE-2-CARBOXYLIC ACID, 95%, 1g

[2-(isopropylthio)ethyl]amine hydrochloride hydrate, 95.0%, 5g

3,5-Bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, 95.0%, 250mg

Ethyl 4-methyl-1H-pyrrole-3-carboxylate, 95.0%, 1g

Tris(2,2,2-trifluoroethyl) Borate>95.0%(T)1g